Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasm Metastasis 2Esophageal Neoplasms 2Colorectal Neoplasms 2Stomach Neoplasms 1Peritoneal Neoplasms 1Hepatocellular Carcinoma Resectable 1Carcinoma, Hepatocellular 1Advanced Gastric Cancer 1

Interventions

Cisplatin 161Fluorouracil 135Paclitaxel 127Radiotherapy 125Oxaliplatin 88Carboplatin 72Docetaxel 71Irinotecan 60pembrolizumab 57Leucovorin 57Capecitabine 57Radiation 48Esophagectomy 44Surgical Procedures, Operative 41Drug Therapy 38Neoadjuvant Therapy 28Cetuximab 25Nivolumab 24Bevacizumab 21camrelizumab 20Trastuzumab 20S 1 (combination) 19Chemoradiotherapy 19Magnetic Resonance Spectroscopy 18Epirubicin 16Albumin-Bound Paclitaxel 16Blood Specimen Collection 15tislelizumab 14Taxes 14Radiotherapy, Intensity-Modulated 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Neoplasms × lobaplatin × Gastrointestinal × Clear all
NCT03413436 2020-08-28

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

Henan Cancer Hospital

Phase 4 Completed
733 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01034683 2010-01-05

Study of Lobaplatin,5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

Taian Cancer Hospital

Phase 3 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡